Evidence map›Paper›PMID 31354246›Full record

ArticleDrug design, development and therapy2019

TMF inhibits miR-29a/Wnt/β-catenin signaling through upregulating Foxo3a activity in osteoarthritis chondrocytes.

Xianhua Huang, Zhixi Chen, Weimei Shi, Rui Zhang, Linfu Li, Hai Liu, Longhuo Wu

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in Drug design, development and therapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Xianhua Huang *College of Pharmacy, Gannan Medical University, Ganzhou, People's Republic of China.ORCID 0000-0001-9479-4128
Zhixi Chen *College of Pharmacy, Gannan Medical University, Ganzhou, People's Republic of China.ORCID 0000-0003-2487-707X
Weimei ShiCollege of Pharmacy, Gannan Medical University, Ganzhou, People's Republic of China.ORCID 0000-0001-6952-5954
Rui ZhangCollege of Pharmacy, Gannan Medical University, Ganzhou, People's Republic of China.ORCID 0000-0001-6602-8389
Linfu LiCollege of Pharmacy, Gannan Medical University, Ganzhou, People's Republic of China.ORCID 0000-0002-3506-5336
Hai LiuCollege of Pharmacy, Gannan Medical University, Ganzhou, People's Republic of China.ORCID 0000-0002-1748-0990
Longhuo WuCollege of Pharmacy, Gannan Medical University, Ganzhou, People's Republic of China.ORCID 0000-0002-3899-9599
Gannan Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Administration, OralAnimalsApoptosisbeta CateninCells, CulturedChondrocytesDisease Models, AnimalDown-RegulationForkhead Box Protein O3LuteolinMicroRNAsOsteoarthritisRatsUp-RegulationWnt Signaling Pathway5,7,3',4'-tetramethylluteolinbeta CateninForkhead Box Protein O3FOXO3 protein, ratLuteolinMicroRNAsMIRN29 microRNA, ratchondrocytes apoptosisFoxo3amiR-29aosteoarthritisTMFWnt/β-catenin

Identifiers

PMID31354246
PMCPMC6590397
OpenAlexW2952464545

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.